Atom | Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Funder: National Institutes of Health

Funding Amounts: No direct funds awarded; provides in-kind access to NINDS URGenT Network resources for up to 2 years per project.

Summary: Enables researchers to access expert support and contract resources for planning, manufacturing, and limited nonclinical development of gene-based therapies for ultra-rare neurological or neuromuscular diseases.

Key Information: No clinical trials allowed; access is in-kind (not monetary); applications must focus on activities prior to IND submission.

Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Sign in to see full grant listing